![](/img/cover-not-exists.png)
Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors
Baird, R. D., Kitzen, J., Clarke, P. A., Planting, A., Reade, S., Reid, A., Welsh, L., Lopez Lazaro, L., de las Heras, B., Judson, I. R., Kaye, S. B., Eskens, F., Workman, P., deBono, J. S., Verweij,Volume:
8
Language:
english
Journal:
Molecular Cancer Therapeutics
DOI:
10.1158/1535-7163.mct-08-1167
Date:
June, 2009
File:
PDF, 154 KB
english, 2009